CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Vivoscreen is developing a new platform for isolating exosomes, which are tiny vesicles important for cancer diagnosis and treatment. The platform combines size exclusion and immune affinity chromatography to improve the efficiency and quality of exosome isolation, aiming to advance their clinical applications.
There is enormous interest in using exosomes in the diagnosis and monitoring of cancer and other diseases, as well as theiruse as therapeutical tools.
These cell-derived vesicles that are present in most bodily fluids are increasingly considered the“future of biomedicine”.However, in terms of clinical applications, we are far from realising exosomes’ full potential.
The greatest barrier is the lack ofdependable protocols for their isolation.Vivoscreen is developing a novel platform for exosome i…
VIVOSCREEN KUTATASFEJLESZTESI KORLATOLT FELELOSSEGU TARSASAG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
